NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Maxim Biomedical

Maxim Biomedical

Private
Rockville, MarylandHealthcare & Life Scienceshttps://maximbio.com/

Last Round

Private Equity

Jul 29, 2024

Total Funding Raised

$62.31M

Company Overview

Maxim Biomedical is a biotechnology company that develops and manufactures in vitro diagnostic and point-of-care testing solutions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

contract development and manufacturing organizationCDMOin vitro diagnosticIVDlateral flow immunoassayELISAdiagnostic manufacturingassay developmentmedical device manufacturingdiagnostic test kitFDA-registered manufacturingbiotech manufacturingwhite label diagnosticsregulatory submission support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Maxim Biomedical Comparables

Compare Maxim Biomedical with similar companies based on industry and business-model similarity.

Maxim Biomedical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
InBios International, Inc.
82%
DCN Diagnostics
81%
Abingdon Health Plc
79%

Maxim Biomedical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityJul 29, 2024
GrantFeb 1, 2024
GrantJan 4, 2024
GrantMay 9, 2023
GrantSep 2, 2020

Key People

Founding team and executive leadership

Jonathan Maa

Chief Executive Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2024

    $4.4M grant from NIH RADx and HHS.

  • Jan 4, 2024

    $50M grant from U.S. Department of Health and Human Services.

Maxim Biomedical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Maxim Biomedical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Maxim Biomedical's valuation, stock price, and market status.

Firmographic Details

HeadquartersRockville, Maryland
Employee Range15
Year Founded2005
Last FundingJul 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.